ALAN HIMMELSBACH: Open Payments
NPI 1487624367 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 84 payments from 18 companies in 2025. Trend: 2023 $3,094 · 2024 $2,020 · 2025 $1,659
Food & beverage: $1,563Education: $96
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $478 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $182 |
| LEO Pharma Inc. | 8 | $176 |
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| Janssen Biotech, Inc. | 7 | $145 |
| Organon LLC | 10 | $108 |
| Galderma Laboratories, L.P. | 4 | $86 |
| Lilly USA, LLC | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| GENZYME CORPORATION | 2 | $51 |
Products named: RINVOQ, SKYRIZI, TREMFYA, ADBRY, COSENTYX, DUPIXENT, ILUMYA, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
